GB959699A - New pyrimidine derivatives - Google Patents
New pyrimidine derivativesInfo
- Publication number
- GB959699A GB959699A GB2102261A GB2102261A GB959699A GB 959699 A GB959699 A GB 959699A GB 2102261 A GB2102261 A GB 2102261A GB 2102261 A GB2102261 A GB 2102261A GB 959699 A GB959699 A GB 959699A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- halo
- reacting
- acid addition
- addition salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Abstract
The invention comprises compounds of general formula: <FORM:0959699/C2/1> wherein R1 represents a hydrogen atom or an alkyl group containing not more than four carbon atoms, Hal represents a halogen atom, and n represents 1 or 2; and their non-toxic acid addition salts; and their preparation by reacting a halo-pyrimidine of formula: <FORM:0959699/C2/2> with a compound of formula R1NH2. Halo-pyrimidines (II) may be obtained by reacting an amidine of formula: <FORM:0959699/C2/3> with an acetoacetic ester and a base to form a 2-halophenylalkyl -4- hydroxy -6- methylpyrimidine which is then treated with a phosphorus oxyhalide. p-Chlorophenacetamidine hydrochloride is prepared by the action of ammoniacal ethanol on ethyl p-chlorophenylacetiminate hydrochloride obtained from p-chlorobenzyl cyanide by treatment with hydrogen chloride in ethanol. Pharmaceutical compositions comprise pyrimidines I or their non-toxic acid addition salts in association with a pharmaceutical carrier. Solid (capsules, tablets, pills, powders, granules) and liquid (emulsions, suspensions) forms for oral administration are described. The compounds have diuretic, natriuretic and saluretic properties and act against hypertension.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2102261A GB959699A (en) | 1961-06-09 | 1961-06-09 | New pyrimidine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2102261A GB959699A (en) | 1961-06-09 | 1961-06-09 | New pyrimidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB959699A true GB959699A (en) | 1964-06-03 |
Family
ID=10155875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2102261A Expired GB959699A (en) | 1961-06-09 | 1961-06-09 | New pyrimidine derivatives |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB959699A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0384370A1 (en) * | 1989-02-22 | 1990-08-29 | Hoechst Aktiengesellschaft | Substituted pyrimidine derivatives, process for their preparation, and their use as tool |
WO1994007867A1 (en) * | 1992-09-28 | 1994-04-14 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
-
1961
- 1961-06-09 GB GB2102261A patent/GB959699A/en not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0384370A1 (en) * | 1989-02-22 | 1990-08-29 | Hoechst Aktiengesellschaft | Substituted pyrimidine derivatives, process for their preparation, and their use as tool |
US5138058A (en) * | 1989-02-22 | 1992-08-11 | Hoechst Aktiengesellschaft | Piperazine substituted pyrimidine derivatives and physiologically tolerated salts thereof |
WO1994007867A1 (en) * | 1992-09-28 | 1994-04-14 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
US5728704A (en) * | 1992-09-28 | 1998-03-17 | Pfizer Inc. | Substituted pyridmidines for control of diabetic complications |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8101073A1 (en) | (Ergolin-yl)-N', N'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them. | |
ES8800145A1 (en) | Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same. | |
ES8300768A1 (en) | Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them. | |
GB937723A (en) | Pyrazolo-pyrimidines and process for their manufacture | |
GB989013A (en) | New guanidines and process for their manufacture | |
GB959699A (en) | New pyrimidine derivatives | |
ES8503676A1 (en) | Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives. | |
GB1144875A (en) | Improvements in and relating to pharmacologically-active guanidine derivatives | |
GB1072414A (en) | New dihydrothieno(3,2-d)pyrimidines | |
ES8100249A1 (en) | Novel hydroxamic acid compounds, method for preparation thereof and medicaments containing such compounds | |
GB1203430A (en) | Heterocyclic spiro compounds | |
GB1031165A (en) | Guanidines, isoureas and isothioureas | |
GB1088102A (en) | Halogen substituted pyrido-pyrimidines | |
GB1375378A (en) | ||
ES8403130A1 (en) | Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds. | |
GB1180249A (en) | Quinoxaline Compounds, their preparation and Compositions containing them | |
KR840008012A (en) | Method for preparing aminoethyl-pyridine and -pyrazine derivatives | |
GB1254270A (en) | Benzoxazepine derivatives | |
GB1181268A (en) | 6-Amino-Uracil-5-Carbonamido-N-sulphonamides and Process for Their Preparation | |
GB1032377A (en) | Asymmetrical pyridoxolyl disulphides and their preparation | |
GB1060069A (en) | Improvements in or relating to phenylethanolamines | |
GB1103524A (en) | Tertiary (1-naphthyl)-alkylamines | |
GB1311334A (en) | 2-substituted aminohexahydrobenzo alpha-quinolizines | |
ES8506711A2 (en) | Amidines, process for their preparation, pharmaceutical compounds containing them and their use. | |
GB947001A (en) | Substituted phenoxyalklylguanidines |